Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

NCT06159049 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT06159049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Completed
Start date
July 21, 2022
Completion date
November 25, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer